ConductScience.org, home

Paper38176263

RNA four-way junction (4WJ) for spontaneous cancer-targeting, effective tumor-regression, metastasis suppression, fast renal excretion and undetectable toxicity.

Li X and 10 others. Biomaterials, 2024. Cited by 24 papers, by iCite.

Cite this record

ConductScience Library. RNA four-way junction (4WJ) for spontaneous cancer-targeting, effective tumor-regression, metastasis suppression, fast renal excretion and undetectable toxicity. Papers, record 38176263. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38176263

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
RNA four-way junction (4WJ) for spontaneous cancer-targeting, effective tumor-regression, metastasis suppression, fast renal excretion and undetectable toxicity.
PubMed
Journal
Biomaterials
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
3.53, provisional
iCite
Revised in PubMed
2025-07-21
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li XXin
2Jin KKai
3Cheng TCTzu-Chun
4Liao YCYou-Cheng
5Lee WJWen-Jui
6Bhullar ASAbhjeet S
7Chen LCLi-Ching
8Rychahou PPiotr
9Phelps MAMitch A
10Ho YSYuan Soon
11Guo PPeixuan

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Lung NeoplasmsMajor topic
NanoparticlesMajor topic
Humans
RNA
Renal Elimination
Drug Delivery Systems
Cell Line, Tumor

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 CA016058NCI NIH HHSUnited StatesP30CA016058PubMed and NIHNIH RePORTER
R01 EY031452NEI NIH HHSUnited StatesR01EY031452PubMed and NIHNIH RePORTER
U01 CA207946NCI NIH HHSUnited StatesU01CA207946PubMed and NIHNIH RePORTER

Download CSV of grants

References110

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132507912Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years?Cancer Metastasis Rev2020https://conductscience.org/library/papers/32507912PubMed
231955577Retained Stability of the RNA Structure in DNA Packaging Motor with a Single Mg2+ Ion Bound at the Double Mg-Clamp Structure.J Phys Chem B2020https://conductscience.org/library/papers/31955577PubMed
327125502Specific Delivery of MiRNA for High Efficient Inhibition of Prostate Cancer by RNA Nanotechnology.Mol Ther2016https://conductscience.org/library/papers/27125502PubMed
429421609Colorectal cancer lung metastasis treatment with polymer-drug nanoparticles.J Control Release2018https://conductscience.org/library/papers/29421609PubMed
511842187RNA hairpin-folding kinetics.Proc Natl Acad Sci U S A2002https://conductscience.org/library/papers/11842187PubMed
629051199Assessment and comparison of thermal stability of phosphorothioate-DNA, DNA, RNA, 2'-F RNA, and LNA in the context of Phi29 pRNA 3WJ.RNA2018https://conductscience.org/library/papers/29051199PubMed
735037525Utilizing RNA nanotechnology to construct negatively charged and ultrasound-responsive nanodroplets for targeted delivery of siRNA.Drug Deliv2022https://conductscience.org/library/papers/35037525PubMed
821102465The emerging field of RNA nanotechnology.Nat Nanotechnol2010https://conductscience.org/library/papers/21102465PubMed
933405070Lumasiran: First Approval.Drugs2021https://conductscience.org/library/papers/33405070PubMed
1033277608Engineering precision nanoparticles for drug delivery.Nat Rev Drug Discov2021https://conductscience.org/library/papers/33277608PubMed
1125770994Nanoparticle-mediated delivery of a rapidly activatable prodrug of SN-38 for neuroblastoma therapy.Biomaterials2015https://conductscience.org/library/papers/25770994PubMed
1211139616TectoRNA: modular assembly units for the construction of RNA nano-objects.Nucleic Acids Res2001https://conductscience.org/library/papers/11139616PubMed
1325652125Delivery of RNA nanoparticles into colorectal cancer metastases following systemic administration.ACS Nano2015https://conductscience.org/library/papers/25652125PubMed
1429802763An RNA Origami Octahedron with Intrinsic siRNAs for Potent Gene Knockdown.Biotechnol J2019https://conductscience.org/library/papers/29802763PubMed
1524823486Activation of c-Met and upregulation of CD44 expression are associated with the metastatic phenotype in the colorectal cancer liver metastasis model.PLoS One2014https://conductscience.org/library/papers/24823486PubMed
1621229999Self-assembling RNA nanorings based on RNAI/II inverse kissing complexes.Nano Lett2011https://conductscience.org/library/papers/21229999PubMed
1734677049The International Society of RNA Nanotechnology and Nanomedicine (ISRNN): The Present and Future of the Burgeoning Field.ACS Nano2021https://conductscience.org/library/papers/34677049PubMed
1831085078Delivery of Anti-miRNA for Triple-Negative Breast Cancer Therapy Using RNA Nanoparticles Targeting Stem Cell Marker CD133.Mol Ther2019https://conductscience.org/library/papers/31085078PubMed
1918935976RNA folding and ribosome assembly.Curr Opin Chem Biol2008https://conductscience.org/library/papers/18935976PubMed
2032902260RNA Nanoparticles as Rubber for Compelling Vessel Extravasation to Enhance Tumor Targeting and for Fast Renal Excretion to Reduce Toxicity.ACS Nano2020https://conductscience.org/library/papers/32902260PubMed

See all 110 referencesDownload CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
42217082Pan-cancer multi-omics analysis identifies SYNGR4 as a novel clinical prognostic biomarker and therapeutic target in lung adenocarcinoma.Discov Oncol2026https://conductscience.org/library/papers/42217082PubMed
42006041RNA-Micelles as Self-Assembling Structures for Efficient Co-Delivery of Synergistic siRNA and Nucleoside Analogues to Treat CRC Lung Metastasis.Adv Funct Mater2026https://conductscience.org/library/papers/42006041PubMed
41640711Nucleic Acid Nanoparticles Redefine Traditional Regulatory Terminology: The Blurred Line between Active Pharmaceutical Ingredients and Excipients.ACS Nano Med2025https://conductscience.org/library/papers/41640711PubMed
41634148Conjugation of hydrophobic drugs to motile pRNA 4WJ nanoparticles for spontaneous tumor targeting and undetectable toxicity.Nat Protoc2026https://conductscience.org/library/papers/41634148PubMed
41104418RNA Nanoparticles Harboring Radioisotopes or Other Imaging Molecules for Spontaneous Tumor Targeting for Early Cancer Diagnosis.RNA Nanomed2025https://conductscience.org/library/papers/41104418PubMed
40921731Developing Potent Therapeutics for Liver Cancer Chemoresistance via an RNA Nanotech and Series-Circuit-Christmas-Bulb Mechanism Targeting ABC Transporters.Mol Pharm2026https://conductscience.org/library/papers/40921731PubMed
40831543Leveraging Immunological Properties of Nucleic Acid Nanoparticles to Improve Cancer Therapy.RNA Nanomed2025https://conductscience.org/library/papers/40831543PubMed
40196906Synergistic RNA particles for spontaneous and specific cancer targeting but low toxicity due to motility and deformation.Nanomedicine (Lond)2025https://conductscience.org/library/papers/40196906PubMed
40193705DNA/RNA hybrids avoid channel gating that leads to the continued packaging of numerous hybrids into the phi29 protein shell.Nucleic Acids Res2025https://conductscience.org/library/papers/40193705PubMed
40131145Non-Viral RNA Therapies for Non-Small Cell Lung Cancer and Their Corresponding Clinical Trials.Mol Pharm2025https://conductscience.org/library/papers/40131145PubMed
40125244Conversion of Chemical Drugs into Targeting Ligands on RNA Nanoparticles and Assessing Payload Stoichiometry for Optimal Biodistribution in Cancer Treatment.RNA Nanomed2024https://conductscience.org/library/papers/40125244PubMed
40125243Targeted Delivery of Potent Chemical Drugs and RNAi to Drug-Resistant Breast Cancer Using RNA-Nanotechnology and RNA-Ligand Displaying Extracellular vesicles.RNA Nanomed2024https://conductscience.org/library/papers/40125243PubMed
40115434pH-responsive bond as a linker for the release of chemical drugs from RNA-drug complexes in endosome or lysosome.RNA Nanomed2024https://conductscience.org/library/papers/40115434PubMed
40045577Using aptamers for targeted delivery of RNA therapies.Mol Ther2025https://conductscience.org/library/papers/40045577PubMed
39978660RNA aptamer-mediated RNA nanotechnology for potential treatment of cardiopulmonary diseases.Pharmacol Res2025https://conductscience.org/library/papers/39978660PubMed
39388598RNA Nanotechnology for Codelivering High-Payload Nucleoside Analogs to Cancer with a Synergetic Effect.Mol Pharm2024https://conductscience.org/library/papers/39388598PubMed
39369270Engineered extracellular vesicles for combinatorial TNBC therapy: SR-SIM-guided design achieves substantial drug dosage reduction.Mol Ther2024https://conductscience.org/library/papers/39369270PubMed
39263430Therapeutic applications of RNA nanostructures.RSC Adv2024https://conductscience.org/library/papers/39263430PubMed
38833534Cracking the Code: Enhancing Molecular Tools for Progress in Nanobiotechnology.ACS Appl Bio Mater2024https://conductscience.org/library/papers/38833534PubMed
38214504In Vitro and In Vivo Evaluation of the Pathology and Safety Aspects of Three- and Four-Way Junction RNA Nanoparticles.Mol Pharm2024https://conductscience.org/library/papers/38214504PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38176263

GET https://conductscience.org/api/papers/v1/38176263/references?page=2